CARMEN BUSTAMANTE: Open Payments
NPI 1720533052 · HIALEAH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,846 in 38 payments from 13 companies in 2025. Trend: 2023 $873 · 2024 $319 · 2025 $1,846
Food & beverage: $1,846
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 10 | $395 |
| Sequel Med Tech, LLC | 3 | $263 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $226 |
| Ascendis Pharma Endocrinology Inc | 3 | $162 |
| Novo Nordisk Inc | 2 | $144 |
| Dexcom, Inc. | 1 | $124 |
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| Lilly USA, LLC | 6 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $111 |
| Amgen Inc. | 1 | $100 |
Products named: t:slim X2 Insulin Pump with Control-IQ, TWIIST, JARDIANCE, Yorvipath, Ozempic, Dexcom G6 Transmitter, GVOKE HYPOPEN, MOUNJARO.
Industry payments across FL — which companies pay providers there.
